Human medicines European public assessment report (EPAR): Celsunax, ioflupane (123I), Date of authorisation: 17/06/2021, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Celsunax, ioflupane (123I), Date of authorisation: 17/06/2021, Revision: 1, Status: Authorised
